SageView Advisory Group’s HCA Healthcare HCA Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$353K Sell
906
-55
-6% -$23.3K 0.01% 449
2026
Q1
$455K Sell
961
-113
-11% -$56.9K 0.02% 370
2025
Q4
$502K Buy
1,074
+11
+1% +$5.11K 0.02% 362
2025
Q3
$453K Buy
1,063
+63
+6% +$24.4K 0.02% 405
2025
Q2
$341K Buy
1,000
+91
+10% +$32.8K 0.01% 461
2025
Q1
$314K Buy
909
+70
+8% +$22.5K 0.01% 462
2024
Q4
$252K Buy
839
+88
+12% +$30.8K 0.01% 503
2024
Q3
$305K Sell
751
-395
-34% -$145K 0.02% 389
2024
Q2
$368K Buy
+1,146
New +$372K 0.02% 392
2024
Q1
Sell
-2,116
Closed -$638K 607
2023
Q4
$638K Buy
2,116
+1,102
+109% +$272K 0.03% 340
2023
Q3
$249K Sell
1,014
-4,651
-82% -$1.27M 0.01% 461
2023
Q2
$1.72M Buy
5,665
+277
+5% +$77K 0.1% 131
2023
Q1
$1.42M Buy
+5,388
New +$1.37M 0.09% 149

Other funds holding HCA

SageView Advisory Group's HCA Position: Q2 2026 in Review

SageView Advisory Group reduced its HCA Healthcare (HCA) stake by 5.7% in Q2 2026, selling an estimated $23.3K and leaving 906 shares worth $353K. The position accounts for 0.01% of the portfolio, ranked #449.

SageView Advisory Group first reported a position in HCA in Q1 2023 and has held it in 13 quarters since. The position peaked at $1.72M in Q2 2023. 835 funds tracked by Wall St. Rank hold HCA as of Q2 2026.

  • SageView Advisory Group held 906 shares of HCA Healthcare worth $353K as of Q2 2026.
  • SageView Advisory Group sold 55 HCA Healthcare shares in Q2 2026, an estimated $23.3K.
  • HCA Healthcare made up 0.01% of SageView Advisory Group's portfolio in Q2 2026, its #449 holding.
  • SageView Advisory Group first reported a position in HCA Healthcare in Q1 2023 and has held it in 13 quarters since.
  • SageView Advisory Group's HCA Healthcare position peaked at $1.72M in Q2 2023.
  • 835 funds tracked by Wall St. Rank held HCA Healthcare as of Q2 2026.

Based on SageView Advisory Group's 13F filing for Q2 2026, filed 10 Aug 2026.